Medicare Enrolled

Dr. Safeer Ashraf, M.D.

Hematology & Oncology · Jacksonville, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
14546 OLD SAINT AUGUSTINE RD, Jacksonville, FL 32258
9042609445
In practice since 2006 (19 years)
NPI: 1639254931 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ashraf from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ashraf? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ashraf

Dr. Safeer Ashraf is a hematology & oncology specialist in Jacksonville, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Ashraf performed 80,331 Medicare services across 2,229 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ashraf received a total of $3,072 from 61 pharmaceutical and/or device companies across 181 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ashraf is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 10% volume in FL $3,072 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 103831 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
80,331
Medicare services
Top 10% in FL for hematology & oncology
2,229
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~4,228 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Iron infusion (Injectafer) 56,250 $1 $4
Epoetin alfa injection (Retacrit) for anemia 7,280 $6 $27
Darbepoetin injection (Aranesp) for anemia 3,700 $2 $14
Denosumab injection (Prolia/Xgeva) 3,600 $18 $39
Blood draw (venipuncture) 1,746 $8 $18
Dexamethasone injection (steroid) 1,557 $0 $1
Complete blood count (CBC) with differential 1,433 $8 $41
Office visit, established patient (20-29 min) 749 $65 $104
Injection, granisetron hydrochloride, 100 mcg 670 $0 $41
Office visit, established patient (30-39 min) 562 $93 $162
Anti-nausea injection (Aloxi/palonosetron) 540 $1 $75
Drug injection, under skin or into muscle 410 $10 $42
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 313 $21 $90
Administration of chemotherapy into vein, 1 hour or less 234 $95 $355
Hospital follow-up visit, moderate complexity 161 $61 $115
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 160 $46 $160
Infusion into a vein for hydration, each additional hour 144 $10 $40
Infusion, normal saline solution , 1000 cc 132 $2 $97
Infusion into a vein for hydration, 31-60 minutes 115 $24 $130
Prothrombin time test (blood clotting) 113 $4 $28
Administration of chemotherapy into vein, each additional hour 94 $21 $80
Initial hospital admission, moderate complexity 64 $98 $225
Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services 60 $71 $70
Injection, diphenhydramine hcl, up to 50 mg 52 $1 $4
Collection of blood sample from implanted device 46 $19 $45
Office visit, established patient, complex (40-54 min) 41 $135 $235
Injection of additional new drug or substance into vein 35 $12 $55
New patient office visit (45-59 min) 24 $124 $265
New patient office visit (30-44 min) 22 $84 $181
Office visit, established patient (10-19 min) 13 $37 $74
Initial hospital admission, high complexity 11 $129 $330
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
71.1% high complexity
22.6% medium
6.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$3,072
Total received (2018-2024)
Avg $439/year across 7 years
Bottom 44% in FL for hematology & oncology
61
Companies
181
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,015 (98.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$57 (1.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$744
2023
$560
2022
$420
2021
$296
2020
$299
2019
$225
2018
$528

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$263
Janssen Biotech, Inc.
$240
Novartis Pharmaceuticals Corporation
$228
GlaxoSmithKline, LLC.
$201
PFIZER INC.
$191
Ipsen Biopharmaceuticals, Inc
$143
Alexion Pharmaceuticals, Inc.
$129
Taiho Oncology, Inc.
$124
Foundation Medicine, Inc.
$123
Incyte Corporation
$102
Merck Sharp & Dohme LLC
$81
GENZYME CORPORATION
$66
Merck Sharp & Dohme Corporation
$63
Eisai Inc.
$61
Celgene Corporation
$56
Dova Pharmaceuticals
$44
Aurobindo Pharma USA, Inc.
$42
AstraZeneca Pharmaceuticals LP
$42
G1 Therapeutics, Inc.
$41
Secura Bio, Inc.
$39
Genentech USA, Inc.
$39
Bayer HealthCare Pharmaceuticals Inc.
$37
JAZZ PHARMACEUTICALS INC.
$35
SECURA BIO, INC.
$33
Pharmacosmos Therapeutics Inc.
$32
Karyopharm Therapeutics Inc.
$30
Exelixis Inc.
$29
EISAI INC.
$29
SERVIER PHARMACEUTICALS LLC
$26
Gilead Sciences, Inc.
$25
Astellas Pharma US Inc
$25
Lexicon Pharmaceuticals, Inc.
$24
Global Blood Therapeutics, Inc.
$24
TESARO, Inc.
$24
Seagen Inc.
$23
SOBI, INC
$21
Tempus AI, Inc
$19
Clovis Oncology, Inc.
$17
Daiichi Sankyo Inc.
$17
Amgen Inc.
$17
Apellis Pharmaceuticals, Inc.
$16
Novo Nordisk Inc
$16
Dendreon Pharmaceuticals LLC
$15
Boehringer Ingelheim Pharmaceuticals, Inc.
$14
MorphoSys, US Inc.
$14
Acceleron Pharma, Inc.
$14
Immunocore Limited
$14
Adaptive Biotechnologies Corporation
$14
MEDIVATION FIELD SOLUTIONS LLC
$13
TerSera Therapeutics LLC
$13
Takeda Pharmaceuticals U.S.A., Inc.
$13
Kite Pharma, Inc.
$13
Sun Pharmaceutical Industries Inc.
$13
Partner Therapeutics, Inc.
$13
TG THERAPEUTICS, INC.
$11
Janssen Pharmaceuticals, Inc
$11
Teva Pharmaceuticals USA, Inc.
$11
SANOFI-AVENTIS U.S. LLC
$11
EMD Serono, Inc.
$10
Menarini Silicon Biosystems, Inc.
$10
Emmaus Medical, Inc.
$9
Top 3 companies account for 23.8% of total payments
Associated products mentioned in payments ›
ADCETRIS · Alecensa · BENDEKA · BLENREP · BOSULIF · Bavencio · CABLIVI · CABOMETYX · CALQUENCE · COPIKTRA · COSELA · Cellsearch · DARZALEX · Doptelet · ELIQUIS · ENJAYMO · Empaveli · Endari · Enhertu · FARYDAK · FOUNDATIONONE · Fabhalta · Farydak · Folotyn · GAZYVA · GILOTRIF · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KIMMTRAK · KISQALI · LEUKINE · LONSURF · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MONJUVI · MONOFERRIC · NovoSeven RT · Nubeqa · OJJAARA · OPDIVO · OXBRYTA · Odomzo · Onivyde · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · Padcev · Polivy · Pomalyst · REBLOZYL · RYBREVANT · Reblozyl · Rubraca · SCEMBLIX · SHINGRIX · SOMATULINE DEPOT · Somatuline Depot · Stivarga · TASIGNA · TIBSOVO · TUKYSA · Tibsovo · UKONIQ · ULTOMIRIS · Ultomiris · VONJO · VPRIV · XARELTO · XPOVIO · XT CDX · XTANDI · Xermelo · Xofigo · ZEJULA · ZEPZELCA · Zevalin · Zoladex · Zydelig · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $4 per 100 Medicare services performed
Looking for a hematology & oncology specialist in Jacksonville?
Compare hematology & oncology specialists in the Jacksonville area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
103
Per 100K population
10.2
County median income
$68,447
Nearest hospital
ASCENSION ST VINCENT'S ST JOHNS COUNTY
4.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ashraf is a mixed practice specialist, with above-average Medicare volume (top 10% in FL), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Ashraf experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Ashraf performed 56,250 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ashraf receive payments from pharmaceutical companies?
Yes. Dr. Ashraf received a total of $3,072 from 61 companies across 181 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ashraf's costs compare to other hematology & oncology specialists in Jacksonville?
Dr. Ashraf's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ashraf) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →